A Scoping Review of Pediatric Kienböck Disease: What Do We Know?

James Rex1,2, Eric Taleghani1,2, Melissa Previtera1

  • 1Division of Hand Surgery, Department of Orthopedics, University of Cincinnati, Cincinnati, OH.

Insights

Kienböck disease in young patients is poorly understood due to limited research. Current literature lacks consistent data on pediatric Kienböck disease management and outcomes, necessitating further investigation.

Area of Science:

  • Orthopedics
  • Pediatric Medicine
  • Radiology

Background:

  • Kienböck disease is a rare condition affecting the lunate bone in children and adolescents.
  • Existing literature is predominantly composed of case reports and series, offering limited evidence for treatment guidelines.
  • Conservative treatment with rigid immobilization is considered standard care, but operative interventions are more frequently reported.

Purpose of the Study:

  • To review and assess the quality of evidence for Kienböck disease in patients under 18.
  • To determine if current literature supports definitive conclusions on management and outcomes for pediatric Kienböck disease.

Main Methods:

  • Comprehensive literature searches were conducted in PubMed, Scopus, and Cochrane Library.
  • Studies were screened for relevance to pediatric and adolescent Kienböck disease, focusing on presentation, diagnosis, interventions, and outcomes.
  • Data extraction was performed on 69 selected studies published between 1976 and 2023.

Main Results:

  • The review included 69 studies, with 57 detailing surgical interventions in 142 patients and 16 reporting conservative management in 26 patients.
  • Surgical approaches varied significantly, with radial shortening osteotomy being the most common procedure.
  • Outcome reporting was inconsistent, primarily focusing on pain and range of motion.

Conclusions:

  • The current body of literature on pediatric and adolescent Kienböck disease is characterized by heterogeneity in data collection and reporting.
  • Despite conservative management being the purported gold standard, most studies focus on operative cases.
  • Prospective research is essential to establish clear management protocols and expected outcomes for this condition.
Abstract

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...